Spring reg­u­la­to­ry agen­da: What’s com­ing soon-ish from the FDA

The FDA’s lack of a per­ma­nent com­mis­sion­er does not seem to be halt­ing its progress to pro­pose and fi­nal­ize dozens of new reg­u­la­tions, with the lat­est batch cov­er­ing every­thing from ad­verse event re­port­ing to sup­ple­men­tal ap­pli­ca­tion sub­mis­sions to an­nu­al re­ports for INDs.

Over­all, FDA ex­pects to re­lease more than 40 new pro­posed reg­u­la­tions and fi­nal­ize an­oth­er 24 in the com­ing months and years.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.